Exploring the therapeutic potential of green tea phytocompounds for pancreatic cancer: An mRNA differential gene expression and pathway analysis study
DOI:
https://doi.org/10.51248/.v43i4.2869Keywords:
Pancreatic cancer, Differentially expressed genes, Microarray, Camellia sinensis, protein protein interactionAbstract
Introduction and Aim: Pancreatic adenocarcinoma, which develops from the exocrine pancreas, is the most prevalent and aggressive type of pancreatic tumour having increased global prevalence, and has more than doubled over the 30 years. The aim of this study is to explore therapeutic potential of Camellia sinensis for pancreatic cancer using mRNA datasets and molecular docking technology.
Materials and Methods: The purpose of the current study is to use computational methods to assess the effectiveness of several Camellia sinensis phytochemicals against Pancreatic cancer. The IMMPAT databank is utilized to retrieve the possible ligands. Molecular docking was methodically carried out using the virtual screening tool PyRx and the BIOVIA Discovery Studio Visualizer to forecast the binding affinity among the phytochemicals and the targeted proteins. Using ADMET filters, the ligands' pharmacological assessment was completed.
Results: The fifty-two phytochemicals identified from Camellia sinensis were initially screened based on their affinity towards the targeted proteins. The ligand binding affinity score suggested that the phytochemical Vitamin E had the greater affinity towards the two targeted proteins and can be a promising therapeutic potential for the study of pancreatic cancer.
Conclusion: The outcomes of this investigation suggested that the phytocompound Vitamin E, upon molecular docking exhibited the highest binding affinity which can be used as a drug candidate for pancreatic cancer.
References
Zhao, Z., Liu, W. Pancreatic cancer: A review of risk factors, diagnosis, and treatment. Technol Cancer Res Treat. 2020;19: 1533033820962117.
Torphy, R.J., Fujiwara, Y., Schulick, R.D. Pancreatic cancer treatment: better, but a long way to go. Surg Today. 2020; 50(10):1117-1125.
Filippini, T., Malavolti, M., Borrelli, F., Izzo, A.A., Fairweather-Tait, S.J., Horneber, M., et al., Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 2020;3(3):CD005004.
Zhao, T., Li, C., Wang, S., Song, X., Green tea (Camellia sinensis): A review of its phytochemistry, pharmacology, and toxicology. molecules.2022;18;27(12):3909.
Hu, X., Ni, S., Zhao, K., Qian, J., Duan, Y., Bioinformatics-led discovery of osteoarthritis biomarkers and inflammatory infiltrates. Frontiers in Immunology. 2022; 13:871008.
Wang, T., Li, B., Nelson, C.E., Nabavi, S., Comparative analysis of differential gene expression analysis tools for single-cell RNA sequencing data. BMC Bioinformatics. 2019; 20:40.
Wu, M., Li, X., Zhang, T., Liu, Z., Zhao, Y., Identification of a nine-gene signature and establishment of a prognostic nomogram predicting overall survival of pancreatic cancer. Front Oncol. 2019;9:996.
Wang, W., Lou, W., Ding, B., Yang, B., Lu, H., Kong, Q., et al., A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. Aging (Albany NY).2019;11(9):2610-2627.
Xie, J., Wu, J., Yang, S., Zhou, H., Network pharmacology-based study on the mechanism of aloe vera for treating cancer. Evid Based Complement Alternat Med. 2021; 2021:6077698.
Mohanraj, K., Karthikeyan, B.S., Vivek-Ananth, R.P., Chand, R.P.B., Aparna, S.R., Mangalapandi, P., et al., IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry and Therapeutics. Scientific Reports. 2018;8(1):4329.
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He J, He S, et al., PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2019; 47(D1):D1102-D1109.
Xiong, G., Wu, Z., Yi, J., Fu, L., Yang, Z., Hsieh, C., et al., ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021; 49(W1):W5-W14.
Zhao, Z., Liu, W., Pancreatic cancer: A review of risk factors, diagnosis, and treatment. Technol Cancer Res Treat. 2020; 19:1533033820962117.
Zeiad, R.K.H.M., Ferren, E.C., Young, D.D., De, Lancy, S.J., Dedousis, D., Schillaci, L.A., et al., A novel homozygous missense mutation in the YARS gene: Expanding the phenotype of YARS multisystem disease. J Endocr Soc. 2021;5(2):bvaa196.
Lu, Y., Yang, Y., Hu, T., Duan, W.M., Identification of key genes and pathways at the downstream of S100PBP in pancreatic cancer cells by integrated bioinformatical analysis. Transl Cancer Res. 2021;10(2):806-816.
Tiwari, A., Tashiro, K., Dixit, A., Soni, A., Vogel, K., Hall, B., et al., Loss of HIF1A from pancreatic cancer cells increases expression of PPP1R1B and degradation of p53 to promote invasion and metastasis. Gastroenterology. 2020; 159(5):1882-1897.e5.
Ashkar, F., Rezaei, S., Salahshoornezhad, S., Vahid, F., Gholamalizadeh, M., Dahka, S.M., et al., The role of medicinal herbs in treatment of insulin resistance in patients with polycystic ovary syndrome: A literature review. Biomol Concepts. 2020;11(1):57-75.
Farhan, M., Green tea catechins: Nature's way of preventing and treating cancer. Int J Mol Sci. 2022;23(18):10713.
Xin, J., Jiang, X., Ben, S., Yuan, Q., Su, L., Zhang, Z., et al., Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study. BMC Med. 2022; 20(1):168.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Biomedicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Plum Analytics
